Search
Search Results
##search.searchResults.foundPlural##
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4751PDF: 1753HTML: 2696Untitled: 210 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4014PDF: 1137HTML: 1925Fig.1: 213Fig. 2: 105Table 1: 199Table2: 215Table 3: 196 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1655PDF: 798HTML: 926cover letter: 262 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1274HTML: 294PDF: 924Suppl. Files: 440 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1257PDF: 754HTML: 4361Figure 1: 150Untitled: 124Untitled: 175 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1537PDF: 596HTML: 181 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1388PDF: 795HTML: 303 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
956PDF: 1127Suppl. Files: 140HTML: 65 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7927PDF: 3226HTML: 1212 -
-
-
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1066PDF: 754HTML: 285 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1280PDF: 904HTML: 286 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2000PDF: 789HTML: 1036 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2891PDF: 677HTML: 1923figure 1: 163figure 2: 173 -
-
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3221PDF: 1518HTML: 412 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1070PDF: 538HTML: 1681Figures: 164Fifures Sanz: 174tables Sanz: 178Untitled: 174 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4201PDF: 1511HTML: 440 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1592PDF: 791HTML: 846jdoe, table 2 infections CML .doc: 188jdoe, table 1 infections CML .doc: 174 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1832PDF: 1041HTML: 226 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2201PDF: 1032HTML: 1975Characteristic of study group: 193 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2729PDF: 1111HTML: 3272 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
812PDF: 805HTML: 114 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3573PDF: 1103HTML: 23326 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1321PDF: 825HTML: 10033cover letter to the editor: 164tile page: 245 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3343PDF: 1284HTML: 1855Fig.1: 195Fig. 2: 198 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3257PDF: 1335HTML: 2618







